Canadian Ebola vaccine to be tested in Europe, Gabon, Kenya

LONDON (Reuters) - Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a program with funding from the Wellcome Trust.

Source: Reuters: Health - October 29, 2014 Category: Consumer Health News Tags: healthNews Source Type: news